Aspen Neuroscience, Inc. · 1 week ago
QC Scientist II
San Diego, CA
Full-time
Onsite
Mid, Senior Level
$122K/yr - $148K/yr
4+ years expAspen Neuroscience, Inc. is seeking a detail-oriented Quality Control (QC) Scientist II to join its team. The role involves contributing to analytical method development, optimization, qualification, and validation for QC testing of cell therapy products, requiring extensive hands-on laboratory experience.
BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics
No H1B
Responsibilities
Serve as a key contributor for analytical method design, development/optimization and troubleshooting, may lead training of junior group members
Serve as a key contributor for qualification and validation of analytical methods and bioinformatics assay transfer
Conduct QC tests in compliance with quality standards and Current Good Manufacturing Practice (cGMP) regulations
Author and revise development report, standard Operating Procedure (SOPs) and technical documentation
Lead investigations of deviation or out-of-specification results in QC laboratory
Apply cGMP requirements applicable to QC laboratory
Provide scientific/technical training, advice, and coaching to junior team members
Qualification
Required
M.S. with a minimum of 4 years of relevant experience, or Ph.D. with minimum of 2 years of relevant experience in Biology, Cell Biology, Microbiology, Molecular Biology or Biochemistry, or related field; or equivalent relevant education and experience
Extensive hands-on laboratory experience in flow cytometry, real-time PCR, cell culture and molecular biology are required
Analytical Skills: Advanced quantitative skills, including statistical analysis and critical evaluation of experimental data; ability to interpret results, draw conclusions, and make recommendations
Cell Culture Techniques: Excellent proficiency in aseptic cell culture techniques
Professional Scientific Expertise: Strong knowledge of scientific concepts and analytical method development in GMP
Technical Writing: Skilled in developing and finalizing SOPs, protocols, and reports that meet regulatory agency standards for clarity and compliance
Organization and Project Management: Highly organized with project coordination abilities and developing skills to lead projects
Communication Skills: Strong verbal and written communication skills to effectively convey scientific ideas, results, and strategic recommendations across departments
Collaboration & Project Management: Ability to coordinate workflows across teams, facilitate study planning and execution, and contribute to cross-functional initiatives; developing skills in project leadership and technical training for colleagues
Detail Oriented: Excellent organizing and documentation skills with a meticulous eye for detail
Problem-Solving Skills: Able to effectively address moderately complex issues through thorough analysis and use judgment in selecting the right course of action
Adaptable: Effective in a fast-paced, startup company environment, and able to adjust workload based on changing priorities
Computer Software: Experience with statistical analysis software, electronic GMP operation system. Effective in Microsoft office suite
Gowning Certification: Ability to independently gown for cleanrooms
Flexible Schedule: Must be willing to work flexible hours including some weekends
Preferred
Experience with stem cells, assay automation, bioinformatics analysis, and GMP operations is preferred
Experience working with real-time PCR and flow cytometry assay automation is preferred
Experience working with bioinformatics analysis is preferred
Experience working with analytical method development in GMP setting is preferred
Experience working with electronic GMP operation system is preferred
Benefits
Medical/Dental insurance benefits
Onsite gym
Other wellness perks
Company
Aspen Neuroscience, Inc.
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and affected organs.
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$387MKey Investors
California Institute for Regenerative MedicineSilicon Valley BankOrbiMed
2025-11-20Series C· $115M
2024-05-15Grant· $8M
2022-12-21Debt Financing· $40M
Leadership Team
Damien McDevitt
President, Chief Executive Officer, & Board Member
Kim Raineri
Chief Technology Officer
Recent News
Longevity.Technology
2026-01-14
Company data provided by crunchbase